These benefits, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the idea of targeting ACKR3 as a novel method to modulate the opioid method, which could open up new therapeutic avenues for opioid-related Ailments.These results counsel that conolidine is able to restri